Brief: Prostatype Genomics Informs About Market Capitalization Value On Certain Financial Websites

Prostatype Genomics AB

15/12/2023 14:05

Dec 15 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * IMPORTANT INFORMATION REGARDING THE MARKET CAPITALIZATION
VALUE
OF PROSTATYPE GENOMICS AB (PUBL) ON CERTAIN FINANCIAL WEBSITES
    * REGRETTABLY INFORMS THAT SOME FINANCIAL WEBSITES PROVIDING
INFORMATION SERVICES ON SHARE DATA, OTHER COMPANY INFORMATION,
SUCH AS AVANZA, NORDNET AND DAGENS INDUSTRI, INCLUDES COMPANY'S
ONGOING RIGHTS ISSUE IN THEIR VALUATION AS IF IT WAS ALREADY
FULLY SUBSCRIBED AND ALSO AT CURRENT SHARE PRICE
    * FOR CURRENT VALUATION PROPOSES SHAREHOLDERS TO EXCLUDE
1.20
BILLION POTENTIAL SHARES FROM RIGHTS ISSUE FROM VALUES PRESENTED
ON FINANCIAL SITES

Source text for Eikon:  ID:nWkrbyK9CL 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))